EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

3 hemophilia patients lift uniQure’s value more than $450M

Shares in uniQure spiked Thursday morning as early clinical data showed hemophilia B patients injected with one of the biotech's gene therapies developed enough b...
Continue Reading →
news

FDA’s Woodcock: ‘The clinical trial system is broken’

The Food and Drug Administration's top drug regulator sharply criticized the current clinical trial regime, calling for industry to embrace more collaborative studie...
Continue Reading →
news

‘Breakthrough’ treatment for peanut allergy awaits FDA check

Peanut allergy makes life more difficult for the millions of people who live with it. "Possible traces" of peanuts in foods pose a constant hidden threat for them, bu...
Continue Reading →
Australasia

PCI Clinical Services Announces Site Expansion to Support Growth and Flexibility

Rockford, IL Center of Excellence to add 30,000 additional sq ft of space. Philadelphia, USA – November 14, 2018 PCI Pharma Services (PCI), a full-service provider of...
Continue Reading →
news

New cancer drug safely boosts radiation therapy

A new clinical trial tests a radiotherapy-boosting drug in the fight against various forms of cancer. Cancer continues to be one of the top causes of death in the Uni...
Continue Reading →
Europe

Ionis, Akcea succeed in heart drug trial, setting up Novartis decision

Akcea Therapeutics and Ionis Pharmaceuticals rolled out successful Phase 2 study results Wednesday showing their drug candidate lowered Lp(a), short for lipoprotein(a...
Continue Reading →
Europe

‘Super’-responder analysis gives more power to Viking’s fatty liver drug

Researchers Monday presented more complete results from Viking Therapeutics' 12-week Phase 2 study of VK2809 at The Liver Meeting 2018, after previously announcing in...
Continue Reading →
news

Sobi snags rights to AstraZeneca drugs in another immunology play

Swedish pharma Sobi has inked a $1.5 billion cash and equity deal to secure rights to two AstraZeneca drugs that it believes will strengthen its position both in the ...
Continue Reading →
news

PCI Clinical Services Announces Site Expansion to Support Growth and Flexibility

Rockford, IL Center of Excellence to add 30,000 additional sq ft of space PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturi...
Continue Reading →
news

Novartis announces clinical collaboration with Pfizer to advance the treatment of NASH

Novartis announced that it has entered into a clinical development agreement with Pfizer which will include a study combining tropifexor and one or more Pfizer compou...
Continue Reading →
Quotient